These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 859758

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Renal clearance and brain tumor localization in mice of 99 m Tc compounds of (Sn), DTPA, (iron-ascorbic acid) DTPA, and iron-ascorbic acid.
    Konikowski T, Glenn HJ, Haynie TP.
    J Nucl Med; 1972 Nov; 13(11):834-42. PubMed ID: 5080017
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Renal and cerebral scintigraphy with the aid of a technetium 99 M-iron-ascorbic acid complex].
    Robillard J, Goussard J, Couette JE, Bloquel J, Cheguillaume J.
    J Radiol Electrol Med Nucl; 1969 May; 50():Suppl 5:385-8. PubMed ID: 5401408
    [No Abstract] [Full Text] [Related]

  • 11. Chemistry of 99mTc tracers. II. In vitro conversion of tagged HEDP and pyrophosphate (bone-seekers) into gluconate (renal agent). Effects of Ca and Fe (ii) on in vivo distribution.
    McRae J, Hambright P, Valk P, Bearden AJ.
    J Nucl Med; 1976 Mar; 17(3):208-11. PubMed ID: 175138
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Radioisotope renal angiography by 99mTc-(Sn)DTPA -- on the differentiation of renal cystic diseases and renal parenchymal tumors -- (author's transl)].
    Ohishi Y, Iio M, Chiba K, Yamada H, Matsui K.
    Kaku Igaku; 1977 Aug; 14(4):461-76. PubMed ID: 926444
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro stabilization of a low-tin bone-imaging agent (99mTc-Sn-HEDP) by ascorbic acid.
    Tofe AJ, Francis MD.
    J Nucl Med; 1976 Sep; 17(9):820-5. PubMed ID: 822138
    [Abstract] [Full Text] [Related]

  • 17. [Organ distribution of 99mTc(Sn)-hydroxide colloid in the rat in dependence on the pH of preparation (author's transl)].
    Syhre R, Spies H, Johannsen B.
    Radiobiol Radiother (Berl); 1976 Sep; 17(6):747-50. PubMed ID: 14355
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Basic studies of various 99mTc-labelled renal agents and clinical application of 99mTc-malate.
    Machida T, Miki M, Ueda M, Tanaka A, Ikeda I.
    Nuklearmedizin; 1977 Feb; 16(1):36-41. PubMed ID: 846865
    [Abstract] [Full Text] [Related]

  • 20. Use of Fe(II) or Sn(II) alone for technetium labeling of albumin.
    Lin MS, Winchell HS, Shipley BA.
    J Nucl Med; 1971 May; 12(5):204-11. PubMed ID: 5580834
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.